Singapore - English - HSA (Health Sciences Authority)

sunward pharmaceutical private limited - dexchlorpheniramine maleate; pseudoephedrine hcl - tablet - 2 mg - dexchlorpheniramine maleate 2 mg; pseudoephedrine hcl 60 mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma manufacturing (bangi) sdn bhd - dexchlorpheniramine maleate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sunward pharmaceutical sdn. bhd. - dexchlorpheniramine maleate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sunward pharmaceutical sdn. bhd. - dexchlorpheniramine maleate; pseudoephedrine hydrochloride -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

prime pharmaceutical sdn. bhd. - dexchlorpheniramine maleate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

y.s.p. industries (m) sdn bhd - dexchlorpheniramine maleate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sunward pharmaceutical sdn. bhd. - dexchlorpheniramine maleate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sunward pharmaceutical sdn. bhd. - dexchlorpheniramine maleate; dextromethorphan; pseudoephedrine hydrochloride -

United States - English - NLM (National Library of Medicine)

capellon pharmaceuticals, llc - dexchlorpheniramine maleate (unii: b10yd955qw) (dexchlorpheniramine - unii:3q9q0b929n) - perennial and seasonal allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild, uncomplicated allergic skin manifestations of urticaria and angioedema amelioration of allergic reactions to blood or plasma dermographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. use in newborn or premature infants this drug should not be used in newborn or premature infants. because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. use in lower respiratory disease antihistamines should not be used to treat lower respiratory tract symptoms including asthma. antihistamines are also contraindicated in the following conditions: - hypersensitivity to dexchlorphenira

United States - English - NLM (National Library of Medicine)

carwin pharmaceutical associates, llc - dexchlorpheniramine maleate (unii: b10yd955qw) (dexchlorpheniramine - unii:3q9q0b929n) - perennial and seasonal allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild, uncomplicated allergic skin manifestations of urticaria and angioedema amelioration of allergic reactions to blood or plasma dermographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. this drug should not be used in newborn or premature infants. because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. antihistamines should not be used to treat lower respiratory tract symptoms including asthma. antihistamines are also contraindicated in the following conditions: